Quantitative evaluation of research results Is the foundation of much scientific research. The Biostatistics Core provides resources to assist in the planning, conduct and analysis of research in such a way that quantitative analyses are appropriate and illuminating. The core also assists In the dissemination of appropriate information both within and external to the Siteman Cancer Center (SCC). Services ofthe Biostatistics Core include: Participating during the design phase of protocols, including the selection of the appropriate study design, primary endpoints, sample size and statistical model. Triage to the appropriate core member. Collaborating in the analysis of data collected for cancer-related protocols conducted by SCC members. The protocols range from analysis of large-scale outcomes research protocols to clinical trials to basic science data. Triage to the appropriate core member. Being available for consulting on the appropriate use of statistical models for all cancer-related studies conducted by SCC members. Providing statistical and methodological review of proposals submitted for SCC internal funding mechanisms. Collaborating in the publication of study results. Providing biostatistical and methodological review of all protocols submitted to the PRMC for full review ' Providing statistical consultation to other SCC Cores with respect to their missions. Important links exit for the Health Behavior, Communications and Outreach Core, the Clinical Trials Core, the High Throughput Screening Core, the Multiplexed Gene Analysis Core, the Small Animal Cancer Imaging Core and the Hereditary Cancer Core. Work with the Bioinformatics Core in deploying CaBIG compatible tools for the collection and extraction of clinical data and the linking with associated tissue samples. Providing informatics services in manipulation and merging of existing clinical electronic data sets.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA091842-11
Application #
8380317
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
11
Fiscal Year
2012
Total Cost
$220,005
Indirect Cost
$55,503
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Salloum, Naji C; Buchalter, Erica Lf; Chanani, Swati et al. (2018) From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation. Pharmacogenomics 19:861-871
Aliev, Fazil; Salvatore, Jessica E; Agrawal, Arpana et al. (2018) A Brief Critique of the TATES Procedure. Behav Genet 48:155-167
Mills, Jason C; Samuelson, Linda C (2018) Past Questions and Current Understanding About Gastric Cancer. Gastroenterology 155:939-944
Shepherd, Andrew J; Copits, Bryan A; Mickle, Aaron D et al. (2018) Angiotensin II Triggers Peripheral Macrophage-to-Sensory Neuron Redox Crosstalk to Elicit Pain. J Neurosci 38:7032-7057
Dehdashti, Farrokh; Wu, Ningying; Bose, Ron et al. (2018) Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer. Breast Cancer Res Treat 169:523-530
Donabedian, Patrick L; Kossatz, Susanne; Engelbach, John A et al. (2018) Discriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse models. EJNMMI Res 8:59
Groves, Andrew P; Gettinger, Katie; Druley, Todd E et al. (2018) Special Therapy and Psychosocial Needs Identified in a Multidisciplinary Cancer Predisposition Syndrome Clinic. J Pediatr Hematol Oncol :
Andley, Usha P; Tycksen, Eric; McGlasson-Naumann, Brittney N et al. (2018) Probing the changes in gene expression due to ?-crystallin mutations in mouse models of hereditary human cataract. PLoS One 13:e0190817
Sáenz, José B; Mills, Jason C (2018) Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer. Nat Rev Gastroenterol Hepatol 15:257-273
Miller, Christopher A; Tricarico, Christopher; Skidmore, Zachary L et al. (2018) A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel RARG-CPSF6 fusion. Blood Adv 2:1295-1299

Showing the most recent 10 out of 1244 publications